HYDROXYCHLOROQUINE SULFATE
Drug
Sandoz Inc.
Total Payments
$31,256
Transactions
8
Doctors
2
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $930.00 | 2 | 2 |
| 2022 | $2,300 | 1 | 0 |
| 2020 | $28,026 | 5 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $30,326 | 6 | 97.0% |
| Consulting Fee | $930.00 | 2 | 3.0% |
Payments by Type
Research
$30,326
6 transactions
General
$930.00
2 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| PATCH 2&3:PREVENTION & TREATMENT OF COVID-19 (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2) WITH HYDROXYCHLOROQUINE | Sandoz Inc. | $11,880 | 0 |
| THE PATCH TRIAL (PREVENTION AND TREATMENT OF COVID-19 WITH HYDROXYCHLOROQUINE) (PATCH) | Sandoz Inc. | $9,000 | 0 |
| CDRB436AUS37T | Sandoz Inc. | $4,536 | 0 |
| BAMM2 BRAF AUTOHPHAGY MEK INHIBITION IN MELANOMA | Sandoz Inc. | $2,300 | 0 |
| HYDROXYCHLOROQUINE FOR COVID-19 POST-EXPOSURE PROPHYLAXIS (PEP) | Sandoz Inc. | $1,800 | 0 |
| OUTCOMES RELATED TO COVID-19 TREATED WITH HYDROXYCHLOROQUINE AMONG IN-PATIENTS WITH SYMPTOMATIC DISEASE (ORCHID) | Sandoz Inc. | $810.00 | 0 |
Top Doctors Receiving Payments for HYDROXYCHLOROQUINE SULFATE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Philadelphia, PA | $30,326 | 6 |
| , MD | Rheumatology | Marietta, OH | $580.00 | 1 |
| Ross Miller | Public Health & General Preventive Medicine | Los Angeles, CA | $350.00 | 1 |
Ad
Manufacturing Companies
- Sandoz Inc. $30,326
- Dr.Reddy's Laboratories,Inc. $930.00
Product Information
- Type Drug
- Total Payments $31,256
- Total Doctors 2
- Transactions 8
About HYDROXYCHLOROQUINE SULFATE
HYDROXYCHLOROQUINE SULFATE is a drug associated with $31,256 in payments to 2 healthcare providers, recorded across 8 transactions in the CMS Open Payments database. The primary manufacturer is Sandoz Inc..
Payment data is available from 2020 to 2023. In 2023, $930.00 was paid across 2 transactions to 2 doctors.
The most common payment nature for HYDROXYCHLOROQUINE SULFATE is "Unspecified" ($30,326, 97.0% of total).
HYDROXYCHLOROQUINE SULFATE is associated with 6 research studies, including "PATCH 2&3:PREVENTION & TREATMENT OF COVID-19 (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2) WITH HYDROXYCHLOROQUINE" ($11,880).